150 related articles for article (PubMed ID: 15319372)
1. A human antibody that promotes remyelination enters the CNS and decreases lesion load as detected by T2-weighted spinal cord MRI in a virus-induced murine model of MS.
Pirko I; Ciric B; Gamez J; Bieber AJ; Warrington AE; Johnson AJ; Hanson DP; Pease LR; Macura SI; Rodriguez M
FASEB J; 2004 Oct; 18(13):1577-9. PubMed ID: 15319372
[TBL] [Abstract][Full Text] [Related]
2. A recombinant human IgM promotes myelin repair after a single, very low dose.
Warrington AE; Bieber AJ; Ciric B; Pease LR; Van Keulen V; Rodriguez M
J Neurosci Res; 2007 Apr; 85(5):967-76. PubMed ID: 17304578
[TBL] [Abstract][Full Text] [Related]
3. Polyreactive antibodies to glatiramer acetate promote myelin repair in murine model of demyelinating disease.
Ure DR; Rodriguez M
FASEB J; 2002 Aug; 16(10):1260-2. PubMed ID: 12060672
[TBL] [Abstract][Full Text] [Related]
4. Spontaneous and induced remyelination in multiple sclerosis and the Theiler's virus model of central nervous system demyelination.
Miller DJ; Rodriguez M
Microsc Res Tech; 1995 Oct; 32(3):230-45. PubMed ID: 8527857
[TBL] [Abstract][Full Text] [Related]
5. Exposure levels of anti-LINGO-1 Li81 antibody in the central nervous system and dose-efficacy relationships in rat spinal cord remyelination models after systemic administration.
Pepinsky RB; Shao Z; Ji B; Wang Q; Meng G; Walus L; Lee X; Hu Y; Graff C; Garber E; Meier W; Mi S
J Pharmacol Exp Ther; 2011 Nov; 339(2):519-29. PubMed ID: 21807883
[TBL] [Abstract][Full Text] [Related]
6. Antibody-Mediated Oligodendrocyte Remyelination Promotes Axon Health in Progressive Demyelinating Disease.
Wootla B; Denic A; Watzlawik JO; Warrington AE; Rodriguez M
Mol Neurobiol; 2016 Oct; 53(8):5217-28. PubMed ID: 26409478
[TBL] [Abstract][Full Text] [Related]
7. Short-term treatment with interferon-alpha/beta promotes remyelination, whereas long-term treatment aggravates demyelination in a murine model of multiple sclerosis.
Njenga MK; Coenen MJ; DeCuir N; Yeh HY; Rodriguez M
J Neurosci Res; 2000 Mar; 59(5):661-70. PubMed ID: 10686594
[TBL] [Abstract][Full Text] [Related]
8. HLA-DRB1*1501 and spinal cord magnetic resonance imaging lesions in multiple sclerosis.
Sombekke MH; Lukas C; Crusius JB; Tejedor D; Killestein J; Arteta D; Martínez A; Uitdehaag BM; Knol DL; Peña AS; Geurts JJ; De Jager PL; Barkhof F; Vrenken H; Polman CH
Arch Neurol; 2009 Dec; 66(12):1531-6. PubMed ID: 20008659
[TBL] [Abstract][Full Text] [Related]
9. Experimental strategies to promote central nervous system remyelination in multiple sclerosis: insights gained from the Theiler's virus model system.
Miller DJ; Asakura K; Rodriguez M
J Neurosci Res; 1995 Jun; 41(3):291-6. PubMed ID: 7563222
[TBL] [Abstract][Full Text] [Related]
10. Monoclonal remyelination-promoting natural autoantibody SCH 94.03: pharmacokinetics and in vivo targets within demyelinated spinal cord in a mouse model of multiple sclerosis.
Hunter SF; Miller DJ; Rodriguez M
J Neurol Sci; 1997 Sep; 150(2):103-13. PubMed ID: 9268236
[TBL] [Abstract][Full Text] [Related]
11. The distribution of inflammatory demyelinated lesions in the central nervous system of rats with antibody-augmented demyelinating experimental allergic encephalomyelitis.
Meeson AP; Piddlesden S; Morgan BP; Reynolds R
Exp Neurol; 1994 Oct; 129(2):299-310. PubMed ID: 7525334
[TBL] [Abstract][Full Text] [Related]
12. Schwann Cell Remyelination in the Multiple Sclerosis Central Nervous System.
Ghezzi L; Bollman B; De Feo L; Piccio L; Trapp BD; Schmidt RE; Cross AH
Lab Invest; 2023 Jun; 103(6):100128. PubMed ID: 36889543
[TBL] [Abstract][Full Text] [Related]
13. Early MRI changes in a mouse model of multiple sclerosis are predictive of severe inflammatory tissue damage.
Nessler S; Boretius S; Stadelmann C; Bittner A; Merkler D; Hartung HP; Michaelis T; Brück W; Frahm J; Sommer N; Hemmer B
Brain; 2007 Aug; 130(Pt 8):2186-98. PubMed ID: 17617655
[TBL] [Abstract][Full Text] [Related]
14. Method of identifying natural antibodies for remyelination.
Warrington AE; Rodriguez M
J Clin Immunol; 2010 May; 30 Suppl 1(0 1):S50-5. PubMed ID: 20387101
[TBL] [Abstract][Full Text] [Related]
15. Antibody-mediated remyelination: relevance to multiple sclerosis.
Bieber A; Asakura K; Warrington A; Kaveri SV; Rodriguez M
Mult Scler; 2000 Oct; 6 Suppl 2():S1-5; discussion S33. PubMed ID: 11188771
[TBL] [Abstract][Full Text] [Related]
16. [Acute posterior cord lesions in multiple sclerosis. An MRI study of the clinical course in 20 cases].
Pou Serradell A; Roquer González J; Perich Alsina X
Rev Neurol (Paris); 2000 Dec; 156(12):1126-35. PubMed ID: 11139729
[TBL] [Abstract][Full Text] [Related]
17. Endogenous leukemia inhibitory factor production limits autoimmune demyelination and oligodendrocyte loss.
Butzkueven H; Emery B; Cipriani T; Marriott MP; Kilpatrick TJ
Glia; 2006 May; 53(7):696-703. PubMed ID: 16498619
[TBL] [Abstract][Full Text] [Related]
18. Gadofluorine M enhancement allows more sensitive detection of inflammatory CNS lesions than T2-w imaging: a quantitative MRI study.
Bendszus M; Ladewig G; Jestaedt L; Misselwitz B; Solymosi L; Toyka K; Stoll G
Brain; 2008 Sep; 131(Pt 9):2341-52. PubMed ID: 18669504
[TBL] [Abstract][Full Text] [Related]
19. Antibody-secreting cells in the central nervous system in an animal model of MS: Phenotype, association with disability, and in vitro production of antibody.
Pachner AR; Brady J; Narayan K
J Neuroimmunol; 2007 Oct; 190(1-2):112-20. PubMed ID: 17919740
[TBL] [Abstract][Full Text] [Related]
20. Demyelination versus remyelination in progressive multiple sclerosis.
Bramow S; Frischer JM; Lassmann H; Koch-Henriksen N; Lucchinetti CF; Sørensen PS; Laursen H
Brain; 2010 Oct; 133(10):2983-98. PubMed ID: 20855416
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
